B
Bona Biotechnology
Biomedical membrane separation and purification equipment manufacturer
About Bona Biotechnology
Shandong Bona Biotechnology Group Co., Ltd. is a high-tech enterprise established in 2012, specializing in material separation, extraction, and purification. The company focuses on the production and operation of membrane filtration and separation equipment, including organic membranes, hollow fiber membranes, and ceramic membranes, as well as separation and purification packing and chromatography services. After its establishment as a group company in 2019, it expanded to include six subsidiaries: three membrane technology companies, two equipment manufacturing companies, and one international trading company.
Bona Biotechnology provides comprehensive solutions for a wide range of industries, including biomedicine, food and beverage, plant extraction, blood products, cosmetics, environmental, petrochemical, and metallurgy. Their product line encompasses experimental, pilot, and industrial-scale membrane filtration systems, alongside chromatography systems, and various membrane elements. The company has a research and development center located in Jinan High-tech Industrial Park and a production base in Zibo. Bona has obtained multiple certifications, including national high-tech enterprise certification, EU CE certification, and various ISO quality, environmental, and occupational health and safety management system certifications.
Over its history, the company has established a technical service center and acquired other membrane production firms to enhance its product specialization and customer support systems. On July 20, 2025, the company announced it had received a round of funding from investors including Jinan Hi-Tech Holding and Lucion Venture Capital.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2012
- Headquarters
- Jinan, China
- Open positions
- None listed
- Dealroom signal
- 14.3/100
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Aug 2024 | $14M | $55M | Luxin Venture Capital · Jinan Hi-tech Group | ↗ |
Growth signals
Latest recorded traffic for Bona Biotechnology is 10 monthly website visits.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- LCLuxin Venture Capital
Jinan Hi-tech Group
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Bona Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bona Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.